Fineotex Chemical Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
331.50 +6.65 (2.05%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
320.45
Today’s High
333.15
52 Week Low
305.2
52 Week High
458
329.70 +4.80 (1.48%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
321.35
Today’s High
332.8
52 Week Low
303.8
52 Week High
458.85
Key Metrics
- Market Cap (In Cr) 3722.54
- Beta 2.14
- Div. Yield (%) 0.49
- P/B 8.05
- TTM P/E 36.76
- Peg Ratio 0.71
- Sector P/E 21.56
- D/E 0
- Open Price 321.5
- Prev Close 324.85
Fineotex Chemical Analysis
Price Analysis
-
1 Week-12.76%
-
3 Months-12.53%
-
6 Month-13.75%
-
YTD-10.07%
-
1 Year2.01%
Risk Meter
- 39% Low risk
- 39% Moderate risk
- 39% Balanced Risk
- 39% High risk
- 39% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0
- 0
- 0
- 0
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 1
- 1
- 1
- 1
Fineotex Chemical News
Ashish Kacholia maintains stake in this chemical stock during Q2. Do you own?
2 min read . 13 Nov 2024Ashish Kacholia portfolio: Deven Choksey sees 50% upside in this chemical stock
2 min read . 20 Aug 2024LIC-owned stock raises ₹342 crore through preferential issue. Share jumps
2 min read . 22 Jul 2024Fineotex Chemical share price: Nirmal Bang sees 25% upside in long-term
2 min read . 02 Jul 2024Fineotex Chemical Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 568.97
- Selling/ General/ Admin Expenses Total
- 21.16
- Depreciation/ Amortization
- 6.02
- Other Operating Expenses Total
- 50.61
- Total Operating Expense
- 426.61
- Operating Income
- 142.36
- Net Income Before Taxes
- 157.57
- Net Income
- 119.81
- Diluted Normalized EPS
- 10.82
- Period
- 2024
- Total Assets
- 548.15
- Total Liabilities
- 101.06
- Total Equity
- 447.09
- Tangible Book Valueper Share Common Eq
- 39.81
- Period
- 2024
- Cashfrom Operating Activities
- 97.38
- Cashfrom Investing Activities
- -46.85
- Cashfrom Financing Activities
- -23.91
- Net Changein Cash
- 26.03
- Period
- 2023
- Total Revenue
- 517
- Selling/ General/ Admin Expenses Total
- 57.92
- Depreciation/ Amortization
- 4.28
- Other Operating Expenses Total
- 1.78
- Total Operating Expense
- 404.97
- Operating Income
- 112.02
- Net Income Before Taxes
- 114.8
- Net Income
- 88.32
- Diluted Normalized EPS
- 7.97
- Period
- 2023
- Total Assets
- 422.7
- Total Liabilities
- 74.03
- Total Equity
- 348.66
- Tangible Book Valueper Share Common Eq
- 30.93
- Period
- 2023
- Cashfrom Operating Activities
- 107.27
- Cashfrom Investing Activities
- -101.84
- Cashfrom Financing Activities
- -6.44
- Net Changein Cash
- 1.36
- Period
- 2022
- Total Revenue
- 368.23
- Selling/ General/ Admin Expenses Total
- 55.37
- Depreciation/ Amortization
- 2.51
- Other Operating Expenses Total
- 1.54
- Total Operating Expense
- 295.92
- Operating Income
- 72.31
- Net Income Before Taxes
- 73.29
- Net Income
- 55.17
- Diluted Normalized EPS
- 4.98
- Period
- 2022
- Total Assets
- 339.49
- Total Liabilities
- 77.35
- Total Equity
- 262.14
- Tangible Book Valueper Share Common Eq
- 23.12
- Period
- 2022
- Cashfrom Operating Activities
- 13.38
- Cashfrom Investing Activities
- -0.74
- Cashfrom Financing Activities
- -5.66
- Net Changein Cash
- 8.39
- Period
- 2021
- Total Revenue
- 218.51
- Selling/ General/ Admin Expenses Total
- 32.33
- Depreciation/ Amortization
- 1.47
- Other Operating Expenses Total
- -10.28
- Total Operating Expense
- 164.93
- Operating Income
- 53.57
- Net Income Before Taxes
- 55.86
- Net Income
- 42.59
- Diluted Normalized EPS
- 3.84
- Period
- 2021
- Total Assets
- 267.08
- Total Liabilities
- 57.74
- Total Equity
- 209.34
- Tangible Book Valueper Share Common Eq
- 18.35
- Period
- 2021
- Cashfrom Operating Activities
- 9.2
- Cashfrom Investing Activities
- -6.53
- Cashfrom Financing Activities
- -4.44
- Net Changein Cash
- -2.49
- Period
- 2020
- Total Revenue
- 196.34
- Selling/ General/ Admin Expenses Total
- 33.86
- Depreciation/ Amortization
- 1.17
- Other Operating Expenses Total
- 3.8
- Total Operating Expense
- 175.35
- Operating Income
- 20.98
- Net Income Before Taxes
- 21.96
- Net Income
- 13.08
- Diluted Normalized EPS
- 1.91
- Period
- 2020
- Total Assets
- 207.85
- Total Liabilities
- 38.16
- Total Equity
- 169.69
- Tangible Book Valueper Share Common Eq
- 14.7
- Period
- 2020
- Cashfrom Operating Activities
- 28.36
- Cashfrom Investing Activities
- -19.01
- Cashfrom Financing Activities
- -3.88
- Net Changein Cash
- 5.85
- Period
- 2019
- Total Revenue
- 182.33
- Selling/ General/ Admin Expenses Total
- 30.29
- Depreciation/ Amortization
- 1
- Total Operating Expense
- 149.41
- Operating Income
- 32.91
- Net Income Before Taxes
- 33.63
- Net Income
- 22.52
- Diluted Normalized EPS
- 2.06
- Period
- 2019
- Total Assets
- 194.74
- Total Liabilities
- 35.94
- Total Equity
- 158.81
- Tangible Book Valueper Share Common Eq
- 13.72
- Period
- 2019
- Cashfrom Operating Activities
- 12.02
- Cashfrom Investing Activities
- 4.18
- Cashfrom Financing Activities
- -3.44
- Net Changein Cash
- 13.58
- Period
- 2018
- Total Revenue
- 142.93
- Selling/ General/ Admin Expenses Total
- 6.18
- Depreciation/ Amortization
- 0.65
- Other Operating Expenses Total
- 19.52
- Total Operating Expense
- 113.5
- Operating Income
- 29.43
- Net Income Before Taxes
- 33.92
- Net Income
- 22.7
- Diluted Normalized EPS
- 2.05
- Period
- 2018
- Total Assets
- 161.1
- Total Liabilities
- 25.39
- Total Equity
- 135.72
- Tangible Book Valueper Share Common Eq
- 11.64
- Period
- 2018
- Cashfrom Operating Activities
- 6.34
- Cashfrom Investing Activities
- -9.41
- Cashfrom Financing Activities
- -3.62
- Net Changein Cash
- -3
- Period
- 2024-09-30
- Total Revenue
- 145.73
- Selling/ General/ Admin Expenses Total
- 6.11
- Depreciation/ Amortization
- 2.37
- Other Operating Expenses Total
- 13.2
- Total Operating Expense
- 111.71
- Operating Income
- 34.02
- Net Income Before Taxes
- 40.7
- Net Income
- 31.85
- Diluted Normalized EPS
- 2.8
- Period
- 2024-09-30
- Total Assets
- 766.04
- Total Liabilities
- 76.52
- Total Equity
- 689.51
- Tangible Book Valueper Share Common Eq
- 58.96
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 25.82
- Cashfrom Investing Activities
- -244.47
- Cashfrom Financing Activities
- 184.75
- Net Changein Cash
- -36.9
- Period
- 2024-06-30
- Total Revenue
- 141.9
- Selling/ General/ Admin Expenses Total
- 5.6
- Depreciation/ Amortization
- 2.25
- Other Operating Expenses Total
- 13.9
- Total Operating Expense
- 108.9
- Operating Income
- 33.01
- Net Income Before Taxes
- 37.63
- Net Income
- 28.75
- Diluted Normalized EPS
- 2.56
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 153.02
- Selling/ General/ Admin Expenses Total
- 5.54
- Depreciation/ Amortization
- 1.85
- Other Operating Expenses Total
- 13.97
- Total Operating Expense
- 116.58
- Operating Income
- 36.44
- Net Income Before Taxes
- 40
- Net Income
- 30.11
- Diluted Normalized EPS
- 2.72
- Period
- 2024-03-31
- Total Assets
- 548.15
- Total Liabilities
- 101.06
- Total Equity
- 447.09
- Tangible Book Valueper Share Common Eq
- 39.81
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 97.38
- Cashfrom Investing Activities
- -46.85
- Cashfrom Financing Activities
- -23.91
- Net Changein Cash
- 26.03
- Period
- 2023-12-31
- Total Revenue
- 138.45
- Selling/ General/ Admin Expenses Total
- 5.45
- Depreciation/ Amortization
- 1.43
- Other Operating Expenses Total
- 11.61
- Total Operating Expense
- 99.53
- Operating Income
- 38.92
- Net Income Before Taxes
- 43.56
- Net Income
- 32.67
- Diluted Normalized EPS
- 2.95
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 145.27
- Selling/ General/ Admin Expenses Total
- 5.05
- Depreciation/ Amortization
- 1.41
- Other Operating Expenses Total
- 12.91
- Total Operating Expense
- 108.46
- Operating Income
- 36.81
- Net Income Before Taxes
- 40.35
- Net Income
- 31.35
- Diluted Normalized EPS
- 2.83
- Period
- 2023-09-30
- Total Assets
- 528.85
- Total Liabilities
- 130.06
- Total Equity
- 398.79
- Tangible Book Valueper Share Common Eq
- 35.45
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 56.29
- Cashfrom Investing Activities
- -52.88
- Cashfrom Financing Activities
- -14.17
- Net Changein Cash
- -5.72
- Period
- 2023-06-30
- Total Revenue
- 132.23
- Selling/ General/ Admin Expenses Total
- 5.12
- Depreciation/ Amortization
- 1.33
- Other Operating Expenses Total
- 12.12
- Total Operating Expense
- 102.04
- Operating Income
- 30.19
- Net Income Before Taxes
- 33.65
- Net Income
- 25.68
- Diluted Normalized EPS
- 2.32
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 137.69
- Selling/ General/ Admin Expenses Total
- 5
- Depreciation/ Amortization
- 1.16
- Other Operating Expenses Total
- 12.17
- Total Operating Expense
- 106.14
- Operating Income
- 31.55
- Net Income Before Taxes
- 33.38
- Net Income
- 25.82
- Diluted Normalized EPS
- 2.34
- Period
- 2023-03-31
- Total Assets
- 422.7
- Total Liabilities
- 74.03
- Total Equity
- 348.66
- Tangible Book Valueper Share Common Eq
- 30.93
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 107.27
- Cashfrom Investing Activities
- -101.84
- Cashfrom Financing Activities
- -6.44
- Net Changein Cash
- 1.36
- Period
- 2022-12-31
- Total Revenue
- 109.23
- Selling/ General/ Admin Expenses Total
- 4.61
- Depreciation/ Amortization
- 1.1
- Other Operating Expenses Total
- 11.86
- Total Operating Expense
- 81.78
- Operating Income
- 27.45
- Net Income Before Taxes
- 29.04
- Net Income
- 22.15
- Diluted Normalized EPS
- 2
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fineotex Chemical Technical
Moving Average
SMA
- 5 Day339.06
- 10 Day356.71
- 20 Day364.32
- 50 Day385.07
- 100 Day378.69
- 300 Day376.51
Fineotex Chemical Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rossari Biotech
- 777.95
- 13.75
- 1.8
- 966
- 657.8
- 4297.86
- BHAGIRADHA CHEMICALS & INDUSTRI
- 325.2
- 13.95
- 4.48
- 448
- 116.51
- 3383.86
- Fineotex Chemical
- 331.5
- 6.65
- 2.05
- 458
- 305.2
- 3671.86
- India Glycols
- 1129.45
- 19.15
- 1.72
- 1545
- 685
- 3496.95
- Savita Oil Technologies
- 479.55
- 2.15
- 0.45
- 655
- 315
- 3313.71
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rossari Biotech
- 33.23
- 4.1
- 16.03
- 7.66
- BHAGIRADHA CHEMICALS & INDUSTRI
- 202.57
- 8.18
- 12.14
- 6.75
- Fineotex Chemical
- 30.92
- 8.29
- 24.67
- 17.46
- India Glycols
- 20.82
- 1.73
- 10.97
- 2.6
- Savita Oil Technologies
- 17.1
- 2.08
- 17.05
- 7.05
Fineotex Chemical Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 13-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results & A.G.M.
- 01-Jun-24
- Preferential issue of shares
- 28-May-24
- Audited Results & Final Dividend
- 16-Feb-24
- Preferential issue of shares
- 14-Feb-24
- Quarterly Results & Interim Dividend
- 09-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results & Others
- 20-May-23
- Audited Results & Final Dividend
- 27-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 10-Sept-24
- 12-Aug-24
- AGM
- 27-Jun-24
- 05-Jun-24
- EGM
- 09-Mar-24
- 22-Feb-24
- EGM
- 15-Sept-23
- 14-Aug-23
- AGM
- 05-Aug-22
- 28-Jun-22
- AGM
- 16-Jul-21
- 17-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- 03-Sept-24
- 03-Sept-24
- 0.4
- 14-Feb-24
- 26-Feb-24
- 26-Feb-24
- 1.2
- 22-May-23
- 08-Sept-23
- 08-Sept-23
- 0.8
- 28-Apr-22
- -
- 28-Jul-22
- 0.4
- 23-Apr-21
- 09-Jul-21
- 08-Jul-21
- 0.3